Childhood Cancer

You are here

Juvenile Myelomonocytic Leukemia (JMML)

Juvenile myelomonocytic leukemia (JMML) is a rare type of leukemia that begins from the myeloid cells. It is neither acute (fast-growing) or chronic (slow-growing) and most often occurs in young children (under age 4). 

Latest Juvenile Myelomonocytic Leukemia (JMML) grants

Alan Cantor, MD, PhD, Principal Investigator
Boston Children's Hospital
Innovation Grants, Awarded 2015
Elliot Stieglitz, MD, Principal Investigator
University of California San Francisco
Young Investigator Grants, Awarded 2015
Mitchell Weiss, M.D., Ph.D., Principal Investigator
Children's Hospital of Philadelphia
Innovation Grants, Awarded 2014

Juvenile Myelomonocytic Leukemia (JMML) Heroes

Latest Juvenile Myelomonocytic Leukemia (JMML) blog posts

Every day, everywhere, children are diagnosed with cancer. Right now, children are in hospitals receiving frontline treatment following a diagnosis. Other children are beginning a clinical trial following a relapse. Still others face long-... more
Last year, we shared the story of 14-year-old Eden Green, who loves to take photos and dance. Eden was in treatment for a form of childhood cancer so rare, that doctors did not have a clinical name for it. After 4 months of treatment on a... more
by Trish Adkins

For Eden, the trouble began when she was 10 years old. The trouble had a name: pain. It seemed normal at first—maybe a side effect from dancing or growing. But then it never went away and then, suddenly, Eden could not... more